Literature DB >> 17918239

The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson's disease.

Paola Costa-Mallen1, Harvey Checkoway, Aram Zabeti, Michael J Edenfield, Phillip D Swanson, W T Longstreth, Gary M Franklin, Terri Smith-Weller, Sayed M H Sadrzadeh.   

Abstract

Oxidative stress and iron have been widely implicated in the etiology of Parkinson's disease (PD). Hemoglobin is the richest source of iron in the body. The human Haptoglobin (Hp) protein is a plasma alpha-2 glycoprotein that removes free Hemoglobin from the circulation and tissues and is important in protection from oxidative stress, in immune system regulation, and angiogenesis. A common genetic polymorphism of Hp exists in the population, where the Hp 1-1, Hp 2-1, and Hp 2-2 forms exhibit profound functional differences. In this study, the Hp genotype corresponding to phenotypes Hp 1-1, 2-1 and 2-2 was determined in 312 idiopathic PD patients and 420 normal control subjects. A significant increase in the number of subjects carrying the Hp 2-1 genotype was present among PD patients. The distribution of Hp genotypes among PD patients (16.0% Hp 1-1, 56.4% Hp 2-1, 27.6% Hp 2-2) was significantly different from the distribution in controls (15.2% Hp 1-1, 48.1% Hp 2-1, 36.7% Hp 2-2) (chi(2) = 6.99, P = 0.030). The odds ratios for PD risk for Hp 2-1 and Hp 1-1 versus Hp 2-2 genotype were 1.51 (1.07-2.12) and 1.36 (0.86-2.15), respectively. Overall, the association of Hp-1 allele with PD resulted stronger among subjects who were never-smokers as compared to ever-smokers. Also, among ever-smokers, Hp genotypes were significantly associated with PD only among women, but not men, indicating the presence of a gene x gender x smoking interaction. To our knowledge, this is the first study that investigates the association of Hp genotypes with the risk of PD. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17918239     DOI: 10.1002/ajmg.b.30593

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  11 in total

1.  Late-life hemoglobin and the incidence of Parkinson's disease.

Authors:  Robert D Abbott; G Webster Ross; Caroline M Tanner; Julie K Andersen; Kamal H Masaki; Beatriz L Rodriguez; Lon R White; Helen Petrovitch
Journal:  Neurobiol Aging       Date:  2010-08-14       Impact factor: 4.673

Review 2.  Correlation of geographic distributions of haptoglobin alleles with prevalence of multiple sclerosis (MS) - a narrative literature review.

Authors:  Vladimir V Bamm; Arielle M Geist; George Harauz
Journal:  Metab Brain Dis       Date:  2016-11-02       Impact factor: 3.584

3.  Poor Clearance of Free Hemoglobin Due to Lower Active Haptoglobin Availability is Associated with Osteoarthritis Inflammation.

Authors:  Ashish Sarkar; Vijay Kumar; Rajesh Malhotra; Hemant Pandit; Elena Jones; Frederique Ponchel; Sagarika Biswas
Journal:  J Inflamm Res       Date:  2021-03-18

4.  Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders.

Authors:  Emanuela Castiglioni; Dario Finazzi; Stefano Goldwurm; Gianni Pezzoli; Gianluca Forni; Domenico Girelli; Federica Maccarinelli; Maura Poli; Maurizio Ferrari; Laura Cremonesi; Paolo Arosio
Journal:  Parkinsons Dis       Date:  2010-10-17

5.  Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease.

Authors:  Paola Costa-Mallen; Cyrus P Zabetian; Shu-Ching Hu; Pinky Agarwal; Dora Yearout; Harvey Checkoway
Journal:  J Neural Transm (Vienna)       Date:  2016-06-27       Impact factor: 3.575

6.  Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells.

Authors:  Marta Biagioli; Milena Pinto; Daniela Cesselli; Marta Zaninello; Dejan Lazarevic; Paola Roncaglia; Roberto Simone; Christina Vlachouli; Charles Plessy; Nicolas Bertin; Antonio Beltrami; Kazuto Kobayashi; Vittorio Gallo; Claudio Santoro; Isidro Ferrer; Stefano Rivella; Carlo Alberto Beltrami; Piero Carninci; Elio Raviola; Stefano Gustincich
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

7.  Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk.

Authors:  Paola Costa-Mallen; Cyrus P Zabetian; Pinky Agarwal; Shu-Ching Hu; Dora Yearout; Ali Samii; James B Leverenz; John W Roberts; Harvey Checkoway
Journal:  Parkinsonism Relat Disord       Date:  2015-07-10       Impact factor: 4.891

8.  Response to the letter "Haptoglobin phenotype and Parkinson disease risk" by Delanghe et al.

Authors:  Paola Costa-Mallen; Cyrus P Zabetian; Pinky Agarwal; Shu-Ching Hu; Dora Yearout; Ali Samii; James B Leverenz; John W Roberts; Harvey Checkoway
Journal:  Parkinsonism Relat Disord       Date:  2016-01       Impact factor: 4.891

9.  Polymorphism of haptoglobin in patients with premature rupture of membrane.

Authors:  Jin-Kyung Cho; Yeun-Hee Kim; In-Yang Park; Jong-Chul Shin; Mi-Kyung Oh; Seon-Joo Park; Nam-Hoon Kim; In-Sook Kim
Journal:  Yonsei Med J       Date:  2008-02-24       Impact factor: 2.759

10.  Analysis of Mitochondrial haemoglobin in Parkinson's disease brain.

Authors:  Freya Shephard; Oliver Greville-Heygate; Susan Liddell; Richard Emes; Lisa Chakrabarti
Journal:  Mitochondrion       Date:  2016-05-12       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.